<!DOCTYPE HTML>
<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<title>input-fr</title>
</head>
<body><div id="lawcontent">
<div id="preface">
<h1 class="erlasstitel botschafttitel ">Ordonnance<br>sur le bureau de notification pour les médicaments vitaux à usage humain</h1>
<p class="man-template-datum-aend ">Modification du 24 novembre 2023</p>
</div>
<div id="preamble">
<p class="man-template-autor ">Le Département fédéral de l’économie, de la formation et de la recherche (DEFR),</p>
<p class="ingress ">vu l’art. 11 de l’ordonnance du 12 août 2015 sur le bureau de notification pour les médicaments vitaux à usage humain<sup><a href="#fn-d8e16" id="fnbck-d8e16">1</a></sup>,</p>
<p class="man-template-verb ">arrête:</p>
<div class="footnotes"><p id="fn-d8e16"><sup><a href="#fnbck-d8e16">1</a></sup><sup></sup> <a href="https://fedlex.data.admin.ch/eli/cc/2015/544" target="_blank">RS <b>531.215.32</b></a></p></div>
</div>
<main id="maintext"><section id="lvl_I"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#lvl_I">I</a>
</h1>
<div class="collapseable"><p class="absatz ">L’annexe de l’ordonnance du 12 août 2015 sur le bureau de notification pour les médicaments vitaux à usage humain est remplacée par la version ci-jointe.</p></div></section><section id="lvl_II"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#lvl_II">II</a>
</h1>
<div class="collapseable">
<p class="absatz ">La présente ordonnance entre en vigueur le 15 janvier 2024.</p>
<p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<td>
					
					<p class="unterschriftenfi1 ">24 novembre 2023</p>
				</td>
				<td>
					
					<p class="unterschriftenfi1 ">Département fédéral de l’économie, de la formation et de la recherche:</p>
					<p class="unterschriftenfi ">Guy Parmelin</p>
				</td>
			</tr>
		</table></div>
</div></section></main><div id="annex"><section id="lvl_u1"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#lvl_u1">Annexe</a>
</h1>
<div class="collapseable">
<p class="titelanhtext ">(art. 3, al. 1)</p>
<section id="lvl_u1/lvl_u1"><h2 class="heading" role="heading" aria-level="2">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#lvl_u1/lvl_u1">Liste des principes actifs</a>
</h2>
<div class="collapseable">
<p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Code ATC*</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Principe actif</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class="man-template-tab-kpf ">Remarque</p>
				</th>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">A07A</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">anti-infectieux intestinaux</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">A09AA02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">enzymes multiples (lipase, protéase, etc.)</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">A10A</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">insulines et analogues</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">A11CC05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">cholécalciférol (vitamine D3)</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">A11DA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">thiamine (vitamine B1)</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">A11DB</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">vitamine B1 en association avec vitamine B6 et/ou vitamine B12</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">A11GA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">acide ascorbique (vitamine C)</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">A11HA02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">pyridoxine (vitamine B6)</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">A11HA04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">riboflavine (vitamine B2)</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">A12CC02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">sulfate de magnésium</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">A12CE02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">sélénite de sodium</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B01AA04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">phenprocoumone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B01AA07</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">acénocoumarol</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B01AB01 </p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">héparine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">&gt; 100 UI/ml</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B01AB02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">antithrombine III</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B01AB04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">daltéparine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B01AB05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">énoxaparine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B01AB06</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">nadroparine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B01AB09</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">danaparoïde</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B01AD02 </p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">altéplase</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">dosage &gt; 2 mg</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B01AD04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">urokinase</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B01AD11</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">ténectéplase</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B01AE03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">argatroban</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B01AE07</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">dabigatran</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B01AF01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">rivaroxaban</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B01AF02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">apixaban</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B01AF03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">édoxaban</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B01AX05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">fondaparinux</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B02AA02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">acide tranexamique</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B02BD</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">facteurs de coagulation</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B05AA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">albumine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B05BA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">acides aminés</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B05BA02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">émulsions lipidiques</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B05BA03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">hydrates de carbone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales avec concentration de glucose ≥ 20 % w/v, volume &gt; 50 ml</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B05BA10</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">solutions pour l’alimentation parentérale, associations</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">poches tricompartimentées pour la voie veineuse centrale</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B05BB01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">électrolytes</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B05DB</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">solutions hypertoniques pour la dialyse péritonéale</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B05XA14</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">glycérophosphate de sodium</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B05XA31</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">électrolytes, associations, y c. oligo-éléments purs</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B05XB02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">alanyl-glutamine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B05XC</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">vitamines</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">B05ZB</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">solutions pour hémofiltration</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">C01CA02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">isoprénaline</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">C01CA03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">noradrénaline</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">C01CA07</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">dobutamine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">C01CA24</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">adrénaline</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">C03CA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">furosémide</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">C07AB02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">métoprolol</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">C07AG01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">labétalol</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">D08AC52</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">chlorhexidine, associations</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">volume &gt; 100 ml</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">D08AG02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">povidone iodée</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">volume &gt; 100 ml</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">D08AJ57 </p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">octénidine, associations</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">D08AX05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">isopropanol</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">D08AX53</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">propanol, associations</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">G02AD05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">sulprostone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">H01AA02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">tétracosactide</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">H01BA02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">desmopressine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">H01BB02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">ocytocine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">H01BB03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">carbétocine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">J01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">antibiotiques à usage systémique</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">sauf J01Z</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">J02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">antifongiques à usage systémique</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">J04A</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">antituberculeux</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">J05AB06</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">ganciclovir</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">J05AB14</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">valganciclovir</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">J05AD01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">foscarnet</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">J05AH02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">oseltamivir</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">J06BA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">immunoglobulines humaines</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">non spécifiques, application extravasculaire</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">J06BA02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">immunoglobulines humaines</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">non spécifiques, application intravasculaire</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">J06BB01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">immunoglobuline anti-D</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">J06BB02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">immunoglobuline antitétanique</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">J06BB03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">immunoglobuline anti-varicelle/zona</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">J06BB04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">immunoglobuline anti-hépatite B</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">J06BB05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">immunoglobuline antirabique</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">J07</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">vaccins</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01AA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">cyclophosphamide</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01AA03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">melphalan</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01AA06</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">ifosfamide</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01AA09</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">bendamustine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01AB01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">busulfan</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01AC01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">thiotépa</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01AD01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">carmustine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01AX03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">témozolomide</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01AX04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">dacarbazine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01BA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">méthotrexate</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01BB02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">mercaptopurine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01BB03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">tioguanine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01BB04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">cladribine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01BB05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">fludarabine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01BB07</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">nélarabine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01BC01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">cytarabine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01BC02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">fluorouracile</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01BC05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">gemcitabine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01BC06</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">capécitabine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01BC07</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">azacitidine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01CA02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">vincristine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01CA04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">vinorelbine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01CB01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">étoposide</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01CD01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">paclitaxel</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01CD02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">docétaxel</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01CD04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">cabazitaxel</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01CE02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">irinotécan</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">ancien code ATC L01XX19</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01CX01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">trabectédine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01DB01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">doxorubicine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01DB03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">épirubicine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01DC01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">bléomycine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01EA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">imatinib</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01EB04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">osimertinib</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01EC02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">dabrafénib</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01EE01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">tramétinib</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01EH02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">nératinib</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01EL01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">ibrutinib</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01EX04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">vandétanib</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01EX10</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">midostaurine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01FA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">rituximab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01FB01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">inotuzumab ozogamicine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01FC01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">daratumumab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01FD01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">trastuzumab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01FD02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">pertuzumab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01FD03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">trastuzumab emtansine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01FE01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">cétuximab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01FF02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">pembrolizumab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01FF03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">durvalumab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01FF05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">atézolizumab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01FG01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">bévacizumab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01FG02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">ramucirumab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01FX02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">gemtuzumab ozogamicine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01FX04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">ipilimumab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01FX05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">brentuximab védotine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01FX07</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">blinatumomab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01XA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">cisplatine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01XA02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">carboplatine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01XA03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">oxaliplatine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01XF01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">trétinoïne</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01XG01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">bortézomib</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01XG02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">carfilzomib</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01XH03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">panobinostat</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01XJ01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">vismodégib</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01XX05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">hydroxycarbamide</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01XX23</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">mitotane</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01XX24</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">pégaspargase</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01XX27</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">trioxyde d’arsenic</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L01XX52</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">vénétoclax</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L02AE03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">goséréline</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L02BA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">tamoxifène</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L02BA03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">fulvestrant</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L03AX03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">vaccin BCG</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L04AA04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">immunoglobuline anti-thymocytes (lapin)</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L04AA13</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">léflunomide</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L04AB06</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">golimumab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L04AC02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">basiliximab</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L04AX01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">azathioprine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes perorales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L04AX03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">méthotrexate</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes perorales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">L04AX04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">lénalidomide</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">M01AB05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">diclofénac</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">M01AB15</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">kétorolac</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">M01AE17</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">dexkétoprofène</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">M03AB01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">suxaméthonium</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">M03AC04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">atracurium</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">M03AC09</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">rocuronium</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">M03AC11</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">cisatracurium</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">M03CA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">dantrolène</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N01AB07</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">desflurane</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N01AF03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">thiopental</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N01AH</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">anesthésiques opioïdes</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N01AH06</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">rémifentanil</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N01AX03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">kétamine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N01AX10</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">propofol</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N01BB02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">lidocaïne</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N01BB03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">mépivacaïne</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N01BB04</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">prilocaïne</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">morphine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AA03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">hydromorphone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AA05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">oxycodone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AA08</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">dihydrocodéine </p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">sauf antitussifs</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AA55</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">oxycodone avec naloxone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AB02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">péthidine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AB03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">fentanyl</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AE01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">buprénorphine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AF02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">nalbuphine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AJ06</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">codéine avec paracétamol</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AJ13</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">tramadol avec paracétamol</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AX01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">tilidine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AX02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">tramadol</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N02AX06</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">tapentadol</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N02BA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">acide acétylsalicylique, y c. acétylsalicylate de lysine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N02BB02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">métamizole sodique</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N02BE01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">paracétamol</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N03AX18</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">lacosamide</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N05BA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">diazépam</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales et gouttes</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N05BA06</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">lorazépam</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N07BC02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">méthadone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">N07BC05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">lévométhadone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">R03CC02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">salbutamol</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">formes parentérales</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">R03CC05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">hexoprénaline</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">S01AD03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">aciclovir</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">pommade ophtalmique</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">S01JA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">fluorescéine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">gouttes ophtalmiques</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">V03AB14</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">protamine</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">V03AB35</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">sugammadex</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">V03AE02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">sévélamer</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">V03AE03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">carbonate de lanthane III</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">V03AE05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">complexe d’oxyhydroxyde de fer III, de saccharose et d’amidon</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">V03AE07</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">acétate de calcium </p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">V03AF03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">folinate de calcium (acide folinique)</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">V08AA</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">produits de contraste hydrosolubles, à élimination rénale, de haute osmolarité</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">V08AB</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">produits de contraste hydrosolubles, à élimination rénale, de basse osmolarité</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">V08BA</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">produits de contraste barytés</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">V08CA</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">produits de contraste paramagnétiques</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr ">V08DA</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr ">produits de contraste pour échographie</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr "></p>
				</td>
			</tr>
			<tr>
				
				
				<td colspan="3"><dl>
<dt>* </dt>
<dd>Les codes ATC (codes des principes actifs figurant dans le <i>Anatomical Therapeutic </i><i>Chemical</i><i> Classification System</i>) peuvent être consultés en anglais (version officielle) sur le site du Centre collaborateur de l’OMS pour la méthodologie sur les statistiques pharmaceutiques à l’adresse suivante: <a href="https://www.whocc.no/atc_ddd_index/" target="_blank">
							www.whocc.no
						</a> &gt; ATC/DDD Index. La répartition des produits reflète les codes ATC attribués par l’Institut suisse des produits thérapeutiques.</dd>
</dl></td>
			</tr>
		</table></div>
<p class="abstand1seite "></p>
</div></section>
</div></section></div>
</div></body>
</html>
